Taysha Gene Therapies, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
SCHEDULE 13D/A: Paul B. Manning and Affiliates Increase Stake in Taysha Gene Therapies to 9.8% Following Recent Share Acquisitions
Paul B. Manning and a group of affiliated entities have increased their beneficial ownership in Taysha Gene Therapies, Inc. to 9.8% of the outstanding common stock through recent purchases in public offerings.